NLRP3 and type 2 diabetes mellitus: In response to calorie restriction and exercise, gene expressions of IL-1β and NLRP3 are reduced in the subcutaneous fat of patients with obesity and type 2 diabetes, accompanied with improvement in insulin sensitivity [19].